DRKS00000371已完成4 期
Comparison of extracorporeal liver support systems MARS and SPAD in a cross over design - MARS/SPAD
Klinik für Anästhesiologie und IntensivtherapieUniversitätsklinikum Jena0 个研究点目标入组 32 人开始时间: 2010年4月8日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 32
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •acute or acute-on-chronic liver failure
- •- Serum bilirubin > 8-10 mg/dl ( 136-171 µmol/l) und plasma disappearance rate of indocyanine green (PDRICG) < 8-10 %
排除标准
- •Age below 18 years
研究者
相似试验
已完成
不适用
Comparison of Two Liver Dialysis Systems : MARS Versus SPAD in Severe Liver FailureLiver Failure, AcuteChronic Hepatic FailureNCT02310542Hospices Civils de Lyon34
已完成
不适用
Elimination of Albumin-Bound Substances by MARS and PrometheusLiver FailureNCT00407004Medical University of Graz10
招募中
不适用
Clinical outcomes of artificial liver support treatments for critically ill patients with liver failureiver failureAcute liver failureAcute on chronic liver failureHepatic encephalopathyCoagulopathyHyperbilirubinemiaHyperammoniaUremiaAcute on chronic liver failureArtificial liver supportExtracorporeal liver support devicesPlasma exchangeDouble plasma molecular adsorption systemAcute liver failureLiver failureTCTR20210924003Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand62
Unknown
不适用
Plasma Exchange and Continuous Hemodiafiltration in Treatment of Wilson's Disease-related Liver FailureWilson DiseaseLiver FailureNCT03589820Third Affiliated Hospital, Sun Yat-Sen University60
招募中
不适用
Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCCImmune-Mediated HepatitisHepatocellular CarcinomaLiver FailureNCT05484908Third Affiliated Hospital, Sun Yat-Sen University60